Biotech firm seeks volunteers for feedback meeting

October 19, 2018
A pharmaceutical/biotech company is hosting a small patient medical advisory board meeting on two half-days on Dec. 7 and 8 in San Francisco. The goal of this meeting it is to convene patients with a diagnosis of multiple sclerosis to gain feedback on a patient-centered approach to MS research. 

This advice will inform and provide personal insight to the pharmaceutical/biotech company’s goal to further MS research through a patient-centered approach and ultimately improve the lives of people living with MS. Topics of discussion will include:

• The potential effect of these initiatives on individual patients and on MS research,
• Motivators for study participation and utilization of digital resources (e.g., websites, phone apps, etc.),
• The measures of MS symptoms and progression that resonate most with patients, and
• Research questions that patients wish to see addressed.

The pharmaceutical/biotech company will reimburse the travel expenses of invited participants, and provide an honorarium as thanks for their time and participation. Participants must:

• Be between the ages of 18 and 65,
• Have a clinical diagnosis of MS,
• Be currently involved in care (e.g., have seen their MS healthcare provider within the past two years),
• Utilize the Internet and/or a smartphone on a regular basis, and
• Be willing and able to travel for a two half-day meeting on Dec. 7 and 8 in San Francisco.

For more information contact Ali Anastasia at Ashfield Healthcare by email or phone: ali.anastasia@ashfieldhealthcare.com or 203-918-9501.

MS Focus Lending Library


Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more

Study uncovers potential risks of common MS treatment


Study finds an increased risk of events such as stroke, migraine, and depression, and abnormalities in the blood with taking beta interferon for MS.
Learn more